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Muscle membrane properties in a pig sepsis model: effect of norepinephrine 
 
Abstract   
 
Introduction: Sepsis-induced myopathy and critical illness myopathy are common causes of 
muscle weakness in intensive care patients.  This study investigated the effect of different mean 
arterial blood pressure (MAP) levels on muscle membrane properties following experimental 
sepsis. 
Methods: Sepsis was induced with faecal peritonitis in 12 out of 18 anesthetized and 
mechanically ventilated pigs. Seven were treated with a high (75-85 mm Hg) and 5 with a low 
(≥60 mm Hg) MAP target for resuscitation. In septic animals, resuscitation was started 12 hours 
after peritonitis induction, and muscle velocity recovery cycles were recorded 30 hours later.  
Results: Muscles in the sepsis/high MAP group showed an increased relative refractory period 
and reduced early supernormality, compared to the remaining septic animals and the control 
group, indicating membrane depolarization and/or sodium channel inactivation. The membrane 
abnormalities correlated positively with norepinephrine dose.  
Discussion: Norepinephrine may contribute to sepsis-induced abnormalities in muscle by 
impairing microcirculation. 
 
Keywords: critical illness myopathy, experimental sepsis, ICU acquired weakness, 
electrophysiology, electromyography, norepinephrine  
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Introduction 
Intensive care unit (ICU) acquired weakness is a frequent complication in critically ill 
patients [1-4]. Typically, patients become symptomatic with generalized muscle weakness and 
failure to wean from mechanical ventilation. ICU-acquired weakness is often caused by sepsis-
induced myopathy, critical illness myopathy (CIM), or a combination of these and other entities 
[5]. Sepsis, systemic inflammatory response syndrome and multiple organ failure have been 
identified as important risk factors for ICU-acquired muscle pathologies [1]. Multiple 
mechanisms have been proposed, such as impaired microcirculation with consecutive 
bioenergetic failure [1, 5], toxic action of cytokines [1, 3, 5], disturbances of electrolyte gradients 
[6 - 8] and muscle catabolism [9 - 13]. Furthermore, it has been shown that during sepsis muscle 
membrane potential changes occur [14 - 17]. Using a pig model, we demonstrated that muscle 
membrane abnormalities consistent with membrane depolarization and/or sodium channel 
inactivation occurred within 6 hours of sepsis induced by faecal peritonitis [18]. Similar changes 
were found in patients diagnosed of probable CIM [6].  
Muscle membrane properties can be assessed in vivo by recording multi-fiber muscle 
velocity recovery cycles (MVRC). Using direct muscle stimulation, a cluster of muscle fibers are 
excited with paired stimuli separated by an inter-stimulus interval (ISI) that is varied between 2 
and 1000 ms. The conduction velocity of the second action potential depends on the ISI [19 - 23]. 
This allows the measurement of muscle relative refractory period (MRRP) and early 
supernormality (ESN). Both measures are sensitive to muscle membrane potential and muscle 
ion channel function. In the early phase of septic myopathy and in probable CIM a prolongation 
of MRRP and a reduction of ESN were found, indicating that muscle membranes are depolarized 
and/or that muscle sodium channel inactivation was increased [6, 18].  
One possible pathophysiological mechanism for development of ICU-acquired muscle 
weakness is reduction of microcirculation, causing bioenergetic failure, eventually leading to 
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ischemic muscle fibre injury. Under physiological conditions, blood flow autoregulation 
maintains organ perfusion constant in the face of changing perfusion pressure. If autoregulation 
is impaired either by a drop of systemic perfusion pressure below a critical value or by failure of 
regulatory mechanisms, organ ischemia can occur. There is an ongoing debate about optimal 
blood pressure management during sepsis [24]. The Surviving Sepsis Guidelines recommend 
vasopressors to achieve and maintain a mean arterial blood pressure (MAP) of at least 65 mm Hg 
in patients not responding to initial fluid resuscitation [25]. Thereby, vasopressors variably affect 
systemic, regional and organ perfusion [26 - 28].  
The aim of the present study was to evaluate the impact of two different MAP target levels 
on muscle membrane properties in an experimental model of sepsis induced by faecal peritonitis.  
 
 
Materials and methods 
Here we report data from two different studies in which neurophysiological measurements 
were carried out. Both studies were performed in accordance with the National Institute of 
Health guidelines for care and use of experimental animals and with the approval of the Animal 
Care Committee of the Canton of Bern, Switzerland (No. BE 88/09 and BE 70/10). The course 
of the disease including hemodynamics and mitochondrial function, and aspects of resuscitation 
have been published previously [29, 30].   
 
Animal Preparation 
Animal preparation was described in detail earlier [29,30]. In brief, 18 domestic pigs (mean 
weight ± SD: 39.4 ± 4.1 kg) were fasted overnight for 12 hours and intramuscularly 
premedicated with ketamine (20 mg/kg) and xylazine (2 mg/kg) before induction of anaesthesia 
with midazolam (0.5mg/kg) and atropine (0.02 mg/kg) followed by orotracheal intubation.  
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Anesthesia was maintained throughout the experiment with continuous intravenous infusions of 
propofol (4 mg/kg/h) and fentanyl (5 µg/kg/h during surgery and 2 µg/kg/h afterwards). If 
necessary, additional boluses of midazolam (5 mg) and fentanyl (50 µg) were administered. 
Neuromuscular blocking agents were not used. Animals were ventilated in a volume-controlled 
mode with a positive end-expiratory pressure of 5 cm H2O, a fraction of inspired oxygen of 0.3 
and a tidal volume of 8 mL/kg (Servo-i
®
, Marquet Critical Care, Solna, Sweden). The respiratory 
rate was adjusted aiming an arterial CO2 partial pressure (PaCO2) of 35 to 45 mmHg. A 
combination of Ringer’s lactate and glucose 50% solutions were infused continuously and 
adjusted to maintain blood glucose in the range of 3.5 to 5 mmol/L. A period up to six hours was 
allowed for hemodynamic stabilization. Afterwards, peritonitis was induced in 12 pigs by 
installation of 2 g/kg of autologous feces dissolved in 200-250 ml (37°C) 5% glucose solution 
into the abdominal cavity. Six animals served as non-septic controls. 
 Resuscitation was started 12 hours after untreated sepsis and lasted for 48 hours. 
Afterwards, the animals were deeply sedated and euthanized with an overdose of potassium 
chloride.  During resuscitation, all animals received intravenous antibiotic treatment with 
piperacillin-tazobactam (2.25 g) every 8 h and deep venous thrombosis prophylaxis with a 
continuous infusion of non-fractionated heparin (10’000 IU/24h). In series 1 [29], resuscitation 
was targeted at MAP ≥60 mmHg [in both septic (n=5) and control animals (n=6)], and in series 2 
[30] (n=7) at 75-85 mmHg (sepsis/high MAP group).  
 
Animal monitoring, biological data and resuscitation strategies 
The following parameters were monitored continuously: hemodynamics, temperature and 
respiratory parameters (S/5 critical Care Monitor
®
, Datex-Ohmeda, GE Healthcare, Helsinki, 
Finland), continuous thermodilution cardiac output (L/min) and mixed venous oxygen saturation 
(SvO2, Vigilance
®
, Edwards Lifescience LLC, Irvine, CA, USA). Data were recorded using a 
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data acquisition and signal analysis software (Soleasy
TM
, National Instruments Corp., Austin, TX, 
USA) and in an electronic patient data management system (Centricity; GE GE Healthcare, 
Helsinki, Finland).  
Blood samples including arterial blood gas analysis were taken at the end of the 
stabilization period and immediately after the electrophysiological investigations. Sodium, 
potassium, glucose, lactate, pH, bicarbonate and base excess were measured. Arterial blood 
samples were analyzed in a blood gas analyzer (GEM Premier 3000 analyzer, Bedford, MA, 
USA), for PaO2, PaCO2 (adjusted to central body temperature), pH, lactate, bicarbonate, base 
excess, sodium and potassium.  
 
Hemodynamic protocol 
Additional fluid boluses and vasoactive drugs were administered according to a 
hemodynamic protocol already published [29,30]. Briefly, fluid boluses of 150 mL Ringer’s 
lactate and 6% hydroxyethyl starch (130/0.4) were given, when pigs were hypovolemic and 
stroke volume increased by more than 10% after the preceding administration. The maximal 
infused dose of hydroxyethyl starch was limited to 30 mL/kg, afterwards only Ringer’s lactate 
was administered. If mixed SvO2 was lower than 50%, dobutamine administration was started (5 
mg/h) and increased by 5 mg/h every 30 min until SvO2 became ≥ 50 % or the maximal dose of 
20 mg/h was reached. If MAP was lower than the targeted resuscitation MAP, norepinephrine 
administration was started. 
 
Recording of muscle multi-fiber velocity recovery cycles 
MVRCs were recorded approximately 48 hours after induction of anesthesia 
(corresponding to 42 hours after induction of peritonitis in the animals with sepsis) using a 
recently described protocol [18, 21]. In brief, multi-fiber responses to direct muscle stimulation 
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were recorded on the foreleg from the extensor digitorum muscle. Stimulation currents were 
delivered through an insulated monopolar needle electrode (TECA, VIASYS Healthcare, 
Madison, Wisconsin, USA), used as a cathode, while a non-polarizable surface electrode (Red 
Dot, 3 M Health Care, Borken, Germany) served as anode. The monopolar stimulation needle 
was inserted perpendicularly into muscle about 15 mm distally to the anode. Stimulus 
waveforms (rectangular current pulses of 0.05 ms duration) generated by a computer were 
converted to current with an isolated linear bipolar-current stimulator (DS 5, Digitimer Ltd., 
Welwyn Garden City, Hertfordshire, UK). Muscle compound action potentials were recorded 
within the same muscle by means of a 30G EMG electrode (Medtronic, Skovlunde, Denmark) 
inserted approximately 20 mm proximal to the stimulating needle. A non-polarizable surface 
electrode served as a ground electrode and was taped on the shoulder of the animal.  
The signal was amplified (gain 1000, bandwidth 1.6 Hz to 10 kHz) and digitized (National 
Instruments NI DAQCARD-6062E, National Instruments Europe Corp., Debrecen, Hungary) 
using a sampling rate of 20 kHz. Stimulation and recording were controlled by QTRAC software 
(written by Hugh Bostock, copyright Institute of Neurology, London, UK).  
Multi-fiber MVRCs with single conditioning stimuli, two test stimuli 10 ms apart, and with 
test stimuli alone were recorded. The ISI between the conditioning stimulus and the test stimulus 
was varied from 1000 to 1.4 ms in 34 steps in an approximately geometric series. 
Data analysis has been described in detail in previous papers [21, 23]. From each MVRC 
we assessed: (1) Relative refractory period, measured as the interpolated ISI at which the 
response latency first recovered to its unconditioned value, and (2) Early supernormality, 
measured as the peak percentage reduction in latency at ISIs shorter than 15ms, (3) Late 
supernormality, measured as the mean percentage reduction in latency at ISIs between 50 and 
150 ms, and (4) Extra late supernormality, measured as the increase in late supernormality due to 
a second conditioning stimulus.  
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Statistical analysis  
Statistical analyses were performed using the QTRAC data analysis software (copyright Institute 
of Neurology, London, United Kingdom), which was also used to generate the figures. 
Hemodynamic data, laboratory results and MVCR parameters of the control, sepsis and 
sepsis/high MAP groups were compared using the Kruskal-Wallis test. To test for differences 
between the two treatment groups (sepsis and sepsis/high MAP) the Mann-Whitney U test was 
used. Correlations between MVRC measures and treatment and other measurements were tested 
by Spearman’s rho. 
 
Results 
Characteristics of the three groups (controls, sepsis and sepsis/high MAP) are summarized 
in Table 1.  42 hours after induction of peritonitis (= 30 hours after initiating the different 
methods of resuscitation), the sepsis/high MAP group had achieved MAP values of 82 ± 4 mm 
Hg and the sepsis group MAP values of 71 ± 8 mm Hg (p = 0.03). Norepinephrine was 
administered to all animals in the sepsis/high MAP group and 2/5 animals in the sepsis group.  
Apart from difference in MAP and a small (0.4˚C) difference in core temperature, none of the 
other non-electrophysiological measurements differed significantly between sepsis and 
sepsis/high MAP groups (Table 1). 
 
Muscle velocity recovery cycles 
Results of electrophysiological investigations are shown in Figure 1 and Table 2. After the 
30 hours of resuscitation, MVRCs of animals of the sepsis/high MAP group were shifted to the 
right and upwards compared to MVRCs of animals of the sepsis group, indicating membrane 
depolarization and/or sodium channel inactivation. This shift corresponded to a significant 
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prolongation of the relative refractory period and a significant reduction in early supernormality 
compared to the sepsis group (Figure 2A, B; Table 2). The late supernormality and extra late 
supernormality were not significantly affected by the sepsis. 
To investigate the cause of the differences in relative refractory period and early 
supernormality between the sepsis/high MAP and sepsis groups, these values were correlated 
separately with the measurements in Table 1, for the whole group of 12 animals with sepsis 
(Table 3).  This shows that despite the significant differences in muscle membrane properties 
between the sepsis/high MAP and sepsis groups, there was no significant correlation between 
individual muscle excitability and MAP measurements. The muscle differences between groups 
cannot therefore be attributed to MAP itself.  The strongest correlations between relative 
refractory period and peak early supernormality were observed with lactate levels and the total 
amount of norepinephrine injected (Table 3).  
 
Discussion 
After 30 hours of resuscitation, muscle excitability testing demonstrated a significant 
increase of refractoriness paralleled by a significant reduction in supernormality in the 
sepsis/high MAP compared to the sepsis group. These changes in muscle excitability 
measurements correlated positively with the cumulative dose of norepinephrine administered 
during resuscitation. 
Muscle excitability testing provides an assessment of muscle fiber properties that does not 
depend on nerve function or neuromuscular transmission [19 - 21, 23, 31].  This method was 
previously used to study the early phase of septic myopathy in a porcine model of peritonitis 
with consecutive sepsis over a period of 27 hours [18]. Muscle membrane dysfunction was found 
to occur within 6 hours of experimental sepsis. Furthermore, similar muscle membrane 
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dysfunction was shown in patients with probable CIM in the chronic state [6], where it provided 
evidence that membrane depolarization and/or sodium channel inactivation occurs.   
We have found similar changes of the two main parameters of muscle membrane 
excitability measurements (prolongation of refractory period, reduction of early supernormality) 
during experimental limb ischemia in healthy volunteers [21] and hypothesized that these 




 pump with consecutive cell membrane 
depolarization. Impaired microcirculation has already been postulated to be a factor in the 
development of myopathy in the critical ill [1, 5]. Theoretically, one would expect that an 
increase of MAP would result in a better organ perfusion if blood flow autoregulation were 
impaired, or unaffected organ perfusion if autoregulation were sustained. Vasopressors have 
been shown to variably affect systemic, regional and organ perfusion [26 - 28]. For example, in 
patients with septic shock, sublingual microcirculatory alterations did not improve in response to 
an increase of MAP with norepinephrine [32]. Furthermore, linear trend analysis demonstrated 
reductions in the capillary and in the perfused capillary densities [32]. We found a positive 
correlation between the cumulative dose of norepinephrine – but not of achieved blood pressure - 
and muscle membrane alterations, possibly related to a norepinephrine-induced reduction of 
microcirculation leading to ischemia in the muscle. The strong correlation between muscle 
membrane changes and lactate, but not pH, support the idea that the membrane changes were 
related to ischemia, with a resultant switch to anaerobic glycolysis.  This hypothesis is also 
supported by the findings of a recent clinical observational study, which demonstrated that the 
required amount of catecholamine was a risk factor for the development of impaired direct 
muscle stimulation [33]. In contrast to our finding of norepinephrine related muscle membrane 
depolarization, earlier studies have shown in isolated muscles that catecholamines stimulate the 
Na+/K+ pump and cause cell membrane hyperpolarization [34 - 36]. This difference might be 
explained by the hypothesis, that in vivo the norepinephrine induced hypoperfusion of the 
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muscle capillaries with consecutive energy depletion and dysfunction of the muscle Na+/K+ 
pump overweighs the direct hyperpolarizing effect of norepinephrine on the muscle cell 
membrane. However, we cannot exclude that muscle membrane depolarization is caused also by 
other factors e.g. sepsis related inflammatory mediators [1, 3, 5]. Since only the sepsis/high MAP 
group showed muscle membrane depolarization (and not the sepsis group), we assume that these 
are of less importance for changes of muscle membrane potential. Furthermore, the strong 
correlation of muscle membrane excitability parameters with lactate supports the hypothesis that 
the membrane changes were related to norepinephrine-induced ischemia. 
Our study has some limitations. First, it was not possible to blind the investigators to the 
treatment regime during the resuscitation phase. Since we used well-defined treatment protocols, 
we think that this did not cause a bias. Second, we cannot provide microcirculation parameters. 
However, the numerically lower systemic perfusion in the sepsis/high MAP compared to sepsis 
group (<80%) together with the massively higher doses of norepinephrine used supports the 
concept of diminished microcirculation in the former group.  The present study was conducted in 
young pigs - the findings might have been different in adult animals or in patients. Nevertheless, 
while critical illness polyneuropathy/myopathy is much less frequently described in pediatric 
compared to adult patients [37], typical findings of the disease have been reported repeatedly in 
animals younger than our pigs [38 - 40]. Finally, our study findings can only be related to septic 
myopathy but not to CIM, since the period of observation was too short. We could also neither 




These results suggest that administration of norepinephrine to elevate MAP during 
resuscitation may contribute to sepsis-induced abnormalities in muscle. This may be due to a 
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norepinephrine-induced reduction of microcirculation, increasing the risk of ischemic muscle 
damage.  Confirmation in humans is needed.  
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List of Abbreviations 
CIM: critical illness myopathy 
ESN: early supernormality 
ICU: intensive care unit 
ISI: inter-stimulus interval  
MAP: mean arterial pressure 
PaCO2: CO2 partial pressure 
PaO2: O2 partial pressure 
SvO2: mixed venous oxygen saturation  
MVRC: muscle velocity recovery cycle 
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Fig. 1. Recordings of muscle velocity recovery cycles in pig extensor digitorum. Mean MVRCs 
for the 7 animals of the sepsis/high MAP group (filled black circles) and the 5 animals of the 
sepsis group (open black circles) compared with 6 non-septic control animals (open grey circles).  
Upper traces: percentage changes in latency following single conditioning stimulus.  Lower 
traces: extra latency changes caused by a second conditioning stimulus, 10 ms earlier.  
 
Fig. 2. Differences between experimental groups 48 hours after induction of anesthesia A: 
muscle relative refractory period, B: peak early supernormality.  Box and whiskers show median, 
inter-quartile range and range; asterisks indicate significant differences by Mann-Whitney U-test, 
* = P < 0.05, ** = P < 0.01 
Page 21 of 24
John Wiley & Sons, Inc.
Muscle & Nerve
This article is protected by copyright. All rights reserved.
 20
Table 1: Measurements from the sepsis and sepsis/high MAP pigs, at 42 hours after induction of 
peritonitis, compared with control animals after same period of anesthesia 
 
 
Values are given as mean ± SD. 
+ 
Mean fluid balance = (Ringer’s lactate basal infusion + glucose 50% 
basal infusion + Ringer’s lactate bolus + hydroxyethyl starch bolus) – (urine output + gastric tube 
output). 
 
Last column gives P values comparing sepsis and sepsis/high MAP groups (Mann-Whitney 
U test). MAP = mean arterial pressure. 








Test   
(P value) 
Sepsis/high MAP 
v. Sepsis   
(P value) 
Core temperature (°C) 39.7 ± 0.7 40.7 ± 0.3 40.3 ± 0.3 0.041 0.048 
Hemodynamics      
     Mean arterial pressure (mmHg) 77.8 ± 19.2 71.0 ± 7.8 81.9 ± 4.3 0.066 0.030 
     Heart rate (bpm) 85.7 ± 11.0 137.4 ± 26.0 164.6 ± 36.0 0.003 0.34 
     Cardiac output (l/min) 5.1 ± 0.9 7.3 ± 1.9 5.8 ± 2.7 0.51 0.20 
     Stroke volume (mL) 58.0 ± 14.1 55.9 ± 11.4 36.4 ± 15.6 0.22 0.11 
Laboratory      
     Sodium (mmol/l) 139.2 ± 2.9 136.0 ± 2.9 133.3 ± 2.4 0.017 0.20 
     Potassium (mmol/l) 3.8 ± 0.3 4.2 ± 0.5 4.9 ± 1.3 0.056 0.20 
     Arterial lactate (mmol/l) 0.40 ± 0.11 0.86 ± 0.19 1.29 ± 0.57 0.004 0.11 
     pH 7.51 ± 0.03 7.44 ± 0.05 7.48 ± 0.09 0.019 0.34 
     Bicarbonate (mmol/l) 30.8 ± 2.5 29.4 ± 1.5 29.2 ± 4.3 0.40 0.76 
     Base excess (mmol/l) 7.0 ± 2.9 5.8 ± 1.6 5.7 ± 5.0 0.41 0.76 
Mean fluid balance (mL/kg/h) + 1.5 ± 0.9 2.8 ± 0.9 3.3 ± 1.3 0.025 0.53 
Norepinephrine (mcg) 0 ± 0 984 ± 1968 35,483 ± 36,927  0.005 0.0051 
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Table 2: Muscle excitability measurements from the sepsis and sepsis/high MAP pigs, at 42 hours after 
induction of peritonitis, compared with control animals after same period of anesthesia 
 
 
Values are given as mean ± SD. Last column gives P values comparing sepsis and sepsis/high MAP 
groups (Mann-Whitney U test). MAP = mean arterial pressure. 
 








Test   
(P value) 
Sepsis/high MAP 
v. Sepsis   
(P value) 
     Relative refractory period (ms) 1.94 ± 0.38 2.35 ± 0.27 5.54 ± 2.28 0.005 0.0025 
     Peak early supernormality (%) 9.9 ± 2.5 6.5 ± 2.2 3.1 ± 2.1    0.006 0.030 
     Late supernormality (%) 1.6 ± 0.6 1.4 ± 1.1 1.3 ± 0.8 0.73 0.76 
     Extra late supernormality (%) 2.0 ± 0.8 1.5 ± 1.1 1.7 ± 1.0 0.46 0.79 
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Table 3: Correlations between muscle velocity recovery cycle parameters and other 




















For each muscle velocity recovery cycle measurement, first column is Spearman's rank 







Peak early supernormality 
(%) 
 
Rho P Rho P 
Core temperature (°C) -0.559 0.057 0.371 0.23 
Mean arterial pressure (mmHg) 0.371 0.23 -0.150 0.64 
Sodium (mmol/l) -0.547 0.063 0.579 0.047 
Potassium (mmol/l) 0.605 0.036 -0.451 0.14 
Lactate (mmol/l) 0.762 0.0040 -0.790 0.0023 
pH -0.124 0.70 0.253 0.43 
Bicarbonate (mmol/l) -0.357 0.25 0.462 0.13 
Base excess (mmol/l) -0.327 0.30 0.414 0.18 
Mean fluid balance (mL/kg/h)  0.524 0.078 -0.720 0.0081 
Norepinephrine (mcg) 0.888 0.00014 -0.671 0.016 
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Figure 1: Recordings of muscle velocity recovery cycles in pig extensor digitorum. Mean MVRCs for the 7 
animals of the sepsis/high MAP group (filled black circles) and the 5 animals of the sepsis group (open black 
circles) compared with 6 non-septic control animals (open grey circles).  Upper traces: percentage changes 
in latency following single conditioning stimulus.  Lower traces: extra latency changes caused by a second 
conditioning stimulus, 10 ms earlier.  
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Figure 2: Differences between experimental groups 48 hours after induction of anesthesia A: muscle relative 
refractory period, B: peak early supernormality.  Box and whiskers show median, inter-quartile range and 
range; asterisks indicate significant differences by Mann-Whitney U-test, * = P < 0.05, ** = P < 0.01  
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